Homeowners Choice Issues Hurricane Hermine Update
Sep 08, 2016 12:30 pm UTC| Business
TAMPA, Fla., Sept. 08, 2016 -- Homeowners Choice Property Casualty Insurance Company, Inc., which is a wholly-owned subsidiary of HCI Group, Inc. (NYSE:HCI) and a leading provider of homeowners insurance in Florida,...
InterDigital Issues Revenue Guidance for Third Quarter 2016
Sep 08, 2016 12:30 pm UTC| Business
WILMINGTON, Del., Sept. 08, 2016 -- InterDigital, Inc. (NASDAQ:IDCC), a mobile technology research and development company, today announced that it expects its total third quarter 2016 revenue to be between $200 million...
Insight Helps Businesses Plan for Success with New Hybrid Cloud Assessment
Sep 08, 2016 12:30 pm UTC| Business
TEMPE, Ariz., Sept. 08, 2016 -- In a recent IDC (International Data Corporation) Multi-Client Study, CloudView 2016, respondents to the survey said they expect to increase their cloud spending by approximately 44% over...
Sep 08, 2016 12:11 pm UTC| Business
MCLEAN, Va., Sept. 08, 2016 -- Intelsat General, a wholly owned subsidiary of Intelsat S.A. (NYSE:I) announced today unprecedented performance in sending signals to and from a high-throughput Intelsat EpicNG satellite...
Numerex Receives Two IoT Evolution Awards
Sep 08, 2016 12:11 pm UTC| Business
ATLANTA, Sept. 08, 2016 -- Numerex Corp (NASDAQ:NMRX), a leading provider of managed enterprise solutions enabling the Internet of Things (IoT) announced today that two of its IoT Managed Services, iManage™ and...
InterCloud Systems Awarded New Contracts Valued at Over $2.6 Million
Sep 08, 2016 12:07 pm UTC| Business
SHREWSBURY, N.J., Sept. 08, 2016 -- InterCloud Systems, Inc. (the "Company" or "InterCloud") (NASDAQ:ICLD), a leading provider of cloud networking orchestration and automation solutions and services, today announced...
Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 18th Annual Global Investment Conference
Sep 08, 2016 12:03 pm UTC| Business
CORAL GABLES, Fla., Sept. 08, 2016 -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating...